Pericarditis resident survival guide: Difference between revisions
Rim Halaby (talk | contribs) |
No edit summary |
||
Line 9: | Line 9: | ||
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. | Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. | ||
* [[Aortic dissection]] | * [[Aortic dissection]] | ||
* [[Myocardial | * [[Myocardial infarction]] | ||
* [[Uremia]] | * [[Uremia]] | ||
Line 21: | Line 21: | ||
==Management== | ==Management== | ||
The following is an algorithm depicting the management of [[acute pericarditis]] in adults.<ref name="pmid15120056">{{cite journal| author=Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y et al.| title=Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. | journal=Eur Heart J | year= 2004 | volume= 25 | issue= 7 | pages= 587-610 | pmid=15120056 | doi=10.1016/j.ehj.2004.02.002 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15120056 }} </ref><ref name="pmid23998693">{{cite journal| author=Klein AL, Abbara S, Agler DA, Appleton CP, Asher CR, Hoit B et al.| title=American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. | journal=J Am Soc Echocardiogr | year= 2013 | volume= 26 | issue= 9 | pages= 965-1012.e15 | pmid=23998693 | doi=10.1016/j.echo.2013.06.023 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23998693 }} </ref><ref name="pmid20177006">{{cite journal| author=Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y| title=Controversial issues in the management of pericardial diseases. | journal=Circulation | year= 2010 | volume= 121 | issue= 7 | pages= 916-28 | pmid=20177006 | doi=10.1161/CIRCULATIONAHA.108.844753 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20177006 }} </ref> | |||
{{Family tree/start}} | {{Family tree/start}} | ||
{{familytree | | | | | | | | | | C01 | | | | | | | | | | | | | | C01=<div style="float: left; text-align: left; padding:1em;">'''Characterize the Clinical, EKG and imaging findings'''<br> | |||
❑ Characteristic [[chest pain]] <br> | |||
:❑ Sharp and pleuritic that is improved by sitting up and leaning forward | |||
❑ [[Pericardial friction rub]] <BR> | |||
:❑ High pitched, scratchy sound at the left sternal border best heard with diaphragm of the stethoscope | |||
:❑ Heard during [[atrial systole]], [[ventricular systole]] and rapid ventricular filling during early [[diastole]] | |||
❑ Suggestive EKG changes <br> | |||
:❑ Diffuse ST elevation with reciprocal ST depression in leads aVR and V1 | |||
❑ Suggestive [[echocardiography]] changes <br> | |||
:❑ New or worsening [[pericardial effusion]] <br> | |||
</div>}} | |||
{{familytree | | | | | | | | | | |!| | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | C01 | | | | | | | | | | | | | | C01=Consider a possible diagnosis of [[acute pericarditis]]}} | |||
{{familytree | | | | | | | | | | |!| | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | A01 | | | | | | | | | | | | | | A01= <div style="float: left; text-align: left; width: 30em; padding:1em;"> '''Characterize the symptoms:'''<br> | {{familytree | | | | | | | | | | A01 | | | | | | | | | | | | | | A01= <div style="float: left; text-align: left; width: 30em; padding:1em;"> '''Characterize the symptoms:'''<br> | ||
'''Symptoms suggestive of [[pericarditis]]:'''<br> | '''Symptoms suggestive of [[pericarditis]]:'''<br> | ||
Line 27: | Line 43: | ||
:❑ Sudden onset | :❑ Sudden onset | ||
:❑ Sharp or dull, aching and pressure like | :❑ Sharp or dull, aching and pressure like | ||
:❑ Pleuritic (exacerbated by [[inspiration]] and coughing) | :❑ Pleuritic (exacerbated by [[inspiration]] and [[coughing]]) | ||
:❑ Retrosternal or radiation to neck, arms, [[trapezius]] muscle ridges | :❑ Retrosternal or radiation to neck, arms, [[trapezius]] muscle ridges | ||
:❑ Affected by position (improved by sitting up and leaning forward)<br> | :❑ Affected by position (improved by sitting up and leaning forward)<br> | ||
Line 57: | Line 73: | ||
:❑ [[Tuberculosis]] | :❑ [[Tuberculosis]] | ||
:❑ [[HIV]] | :❑ [[HIV]] | ||
:❑ Travel history<br> | :❑ Travel history | ||
<div class="mw-collapsible-content"> <div class="mw-collapsible mw-collapsed"> | |||
::❑ Travel to Central or South America ([[Chagas disease]]) | |||
::❑ Travel to Central Asia or South Africa ([[Tuberculosis]]) | |||
::❑ Travel to North and Central America (Ohio and Mississippi River valleys) ([[Histoplasmosis]]) | |||
::❑ Travel to North America ([[Blastomycosis]]) | |||
</div></div><br> | |||
❑ [[Pericarditis causes#Causes by Organ System|Medications]]<div class="mw-collapsible-content"> <div class="mw-collapsible mw-collapsed"> | ❑ [[Pericarditis causes#Causes by Organ System|Medications]]<div class="mw-collapsible-content"> <div class="mw-collapsible mw-collapsed"> | ||
:❑ [[5-Fluorouracil]] | :❑ [[5-Fluorouracil]] | ||
:❑ [[Amiodarone]] | :❑ [[Amiodarone]] | ||
:❑ [[Anticoagulants]] | :❑ [[Anticoagulants]] | ||
:❑ [[Cyclosporine]] | :❑ [[Cyclosporine]] | ||
:❑ [[Cyclyphosphamide]] | :❑ [[Cyclyphosphamide]] | ||
Line 83: | Line 105: | ||
:❑ [[Cardiac surgery]] | :❑ [[Cardiac surgery]] | ||
:❑ [[Radiation exposure]] | :❑ [[Radiation exposure]] | ||
:❑ | :❑ [[Dressler's syndrome]] | ||
:❑ [[Postpericardiotomy syndrome]] | |||
:❑ Trauma history <br> | :❑ Trauma history <br> | ||
</div>}} | </div>}} | ||
Line 95: | Line 118: | ||
:❑ [[Blood pressure]] | :❑ [[Blood pressure]] | ||
::❑ Normal (usual) | ::❑ Normal (usual) | ||
::❑ [[Hypotension]] (in cardiac tamponade) | ::❑ [[Hypotension]] (in [[cardiac tamponade]]) | ||
:❑ [[Temperature]] | :❑ [[Temperature]] | ||
::❑ [[Fever]] less than 39°C or 102.2°F | ::❑ [[Fever]] less than 39°C or 102.2°F | ||
::❑ [[Hypothermic]] (in elderly and [[renal failure]]) | ::❑ [[Hypothermic]] (in elderly and [[renal failure]]) | ||
:❑ [[Respiratory rate]] | :❑ [[Respiratory rate]] | ||
::❑ [[Tachypnea]] | ::❑ [[Tachypnea]] | ||
❑ Cardiovascular: <br> | ❑ Cardiovascular: <br> | ||
:❑ Heart sounds | :❑ Heart sounds | ||
::❑ Normal (usual) | ::❑ Normal (usual) | ||
::❑ Distant and muffled (in cardiac tamponade) | ::❑ Distant and muffled (in [[cardiac tamponade]]) | ||
:❑ [[Pericardial friction rub]] | :❑ [[Pericardial friction rub]] | ||
::❑ High pitched, scratchy or squeaky sound | ::❑ High pitched, scratchy or squeaky sound | ||
::❑ Best heard at the left sternal border | ::❑ Best heard at the left sternal border | ||
::❑ Best heard with the diaphragm of the stethoscope | ::❑ Best heard with the diaphragm of the stethoscope | ||
::❑ Vary in intensity overtime and need reapeated examinations | ::❑ Vary in intensity overtime and need reapeated examinations | ||
{{#ev:youtube|watch?v=EUCp_3_vwtw}} | |||
:❑ [[Jugular venous pulse]] | :❑ [[Jugular venous pulse]] | ||
::❑ Elevated (in tamponade and [[constrictive pericarditis]]) <br> | ::❑ Elevated (in [[cardiac tamponade]] and [[constrictive pericarditis]]) <br> | ||
::❑ [[Kussmaul sign]] (in constrictive pericarditis) <br> | ::❑ [[Kussmaul sign]] (in [[constrictive pericarditis]]) <br> | ||
:❑ Any [[ | :❑ Any [[murmur]]<br> | ||
:❑ Percuss cardiac dullness<br> | :❑ Percuss cardiac dullness<br> | ||
::❑ Dullness beyond the apical point of maximal impulse is seen in [[pericardial effusion]]<br> | ::❑ Dullness beyond the apical point of maximal impulse is seen in [[pericardial effusion]]<br> | ||
❑ Respiratory system: <br> | ❑ Respiratory system: <br> | ||
:❑ [[Wheeze]] or [[ | :❑ [[Wheeze]] or [[rales]]<br> | ||
:❑ [[Pleural effusion]]<br> | :❑ [[Pleural effusion]]<br> | ||
❑ Abdominal examination | ❑ Abdominal examination | ||
:❑ Pulsatile [[hepatomegaly]] (in constrictive pericarditis) | :❑ Pulsatile [[hepatomegaly]] (in [[constrictive pericarditis]]) | ||
:❑ [[Ascites]]<br> | :❑ [[Ascites]]<br> | ||
</div>}} | </div>}} | ||
Line 137: | Line 160: | ||
---- | ---- | ||
❑ [[Pericarditis electrocardiogram|Typical findings in pericarditis]] | ❑ [[Pericarditis electrocardiogram|Typical findings in pericarditis]] | ||
:❑ | :❑ ST segment elevation in leads I, II, aVL, aVF, and V3-V6 | ||
:❑ PR-segment depression | :❑ PR-segment depression | ||
:❑ Low-voltage QRS complexes (in large [[pericardial effusion]] and [[constrictive pericarditis]]) | |||
[[Image:Acute-pericarditis.jpg|center|200px]] | [[Image:Acute-pericarditis.jpg|center|200px]] | ||
<br> | * Above EKG shows ST elevation in leads I, II, V2, V3, V4, V5, and V6 depicting acute pericarditis<br> | ||
❑ [[Electrical alternans]] (in cardiac tamponade)<br> | ❑ [[Electrical alternans]] (in [[cardiac tamponade]])<br> | ||
---- | ---- | ||
'''Order imaging (urgent):'''<br> | '''Order imaging (urgent):'''<br> | ||
---- | ---- | ||
❑ [[Chest X-ray]] <br> | ❑ [[Chest X-ray]] <br> | ||
:❑ [[ | :❑ A flask-shaped, enlarged cardiac silhouette ([[pericardial effusion]] and [[cardiac tamponade]]) | ||
:❑ Clear lung fields | :❑ Clear lung fields | ||
[[Image:Pericardial effusion_3.jpg|thumb|150px|left|Pericardial effusion]] | [[Image:Pericardial effusion_3.jpg|thumb|150px|left|Pericardial effusion]] | ||
Line 152: | Line 176: | ||
❑ [[Echocardiography]] <br> | ❑ [[Echocardiography]] <br> | ||
:❑ [[Pericarditis echocardiography|Diagnostic]] | :❑ [[Pericarditis echocardiography|Diagnostic]] | ||
:❑ [[ | :❑ Presence of moderate and large [[pericardial effusion]] | ||
:❑ Right atrial collapse | |||
:❑ Diastolic collapse of right ventricle and left atrium (specific for cardiac tamponade) | |||
:❑ Valvular abnormalities and masses | |||
</div>}} | </div>}} | ||
{{familytree | | | | | | | | | | |!| | | | | | | | | }} | {{familytree | | | | | | | | | | |!| | | | | | | | | }} | ||
{{familytree | | | | | | | | | | C01 | | | | | | | | | | | | | | C01=<div style="float: left; text-align: left; padding:1em;">'''Diagnosis of acute pericarditis:'''<br> | {{familytree | | | | | | | | | | C01 | | | | | | | | | | | | | | C01=<div style="float: left; text-align: left; padding:1em;">'''Diagnosis of acute pericarditis:'''<br> | ||
'''Atleast two of the following criteria:'''<br> | '''Atleast two of the following criteria:'''<br> | ||
❑ Characteristic chest pain <br> | ❑ Characteristic [[chest pain]] <br> | ||
❑ Pericardial friction rub <BR> | ❑ [[Pericardial friction rub]] <BR> | ||
❑ Suggestive EKG changes <br> | ❑ Suggestive EKG changes <br> | ||
❑ New or worsening pericardial effusion <br> | ❑ New or worsening [[pericardial effusion]] <br> | ||
</div>}} | </div>}} | ||
{{familytree | | | | | | | |,|-|-|^|-|-|.| | | | | | | }} | {{familytree | | | | | | | |,|-|-|^|-|-|.| | | | | | | }} | ||
{{familytree | | | | | | | D01 | | | | D02 | | | | | | D01=Yes| D02=No or equivocal}} | {{familytree | | | | | | | D01 | | | | D02 | | | | | | D01=Yes| D02=No or equivocal}} | ||
{{familytree | | | | | | | |!| | | |,|-|^|-|-|.| | | }} | {{familytree | | | | | | | |!| | | |,|-|^|-|-|.| | | }} | ||
{{familytree | | | | | | | E01 | | E02 | | | E03 | | E01= ❑ [[Acute pericarditis]] <br> ❑ [[Myopericarditis]] <br> * Elevated cardiac enzymes <br>* | {{familytree | | | | | | | E01 | | E02 | | | E03 | | E01= ❑ [[Acute pericarditis]] <br> ❑ [[Myopericarditis]] <br> * Elevated cardiac enzymes <br>* Global or focal myocardial dysfunction on echo | E02=Consider cardiac MRI (CMR) | E03=Consider [[Pericarditis differential diagnosis|alternative diagnosis]] and treat accordingly}} | ||
{{familytree | | | | | | | |!| | | |!| | | | | | | | }} | {{familytree | | | | | | | |!| | | |!| | | | | | | | }} | ||
{{familytree | | | | | | | |!| | | F01 | | | | | | | F01= Treat as acute pericarditis or myopericarditis if there is delayed enhancement on CMR}} | {{familytree | | | | | | | |!| | | F01 | | | | | | | F01= Treat as acute pericarditis or myopericarditis if there is delayed enhancement on CMR}} | ||
{{familytree | | | | | | | |`|-|v|-|'| | | | | | | | }} | {{familytree | | | | | | | |`|-|v|-|'| | | | | | | | }} | ||
{{familytree | | | | | | | | | G01 | | | | | | | | | G01=<div style="float: left; text-align: left; padding:1em;">'''High risk features'''<br> | {{familytree | | | | | | | | | G01 | | | | | | | | | G01=<div style="float: left; text-align: left; padding:1em;">'''High risk features'''<br> | ||
❑ Fever >38°C <br> | ❑ [[Fever]] >38°C <br> | ||
❑ Leucocytosis <BR> | ❑ [[Leucocytosis]] <BR> | ||
❑ Subacute presentation <BR> | ❑ Subacute presentation <BR> | ||
❑ Cardiac tamponade <br> | ❑ [[Cardiac tamponade]] <br> | ||
❑ Large pericardial effusion <br> | ❑ Large [[pericardial effusion]] <br> | ||
❑ Elevated troponins (myopericarditis) <BR> | ❑ Elevated troponins ([[myopericarditis]]) <BR> | ||
❑ Concurrent oral [[anticoagulation]] <br> | ❑ Concurrent oral [[anticoagulation]] <br> | ||
❑ Lack of response to [[aspirin]] or [[NSAIDs]] after at least 1 wk of therapy <br> | ❑ Lack of response to [[aspirin]] or [[NSAIDs]] after at least 1 wk of therapy <br> | ||
❑ Immunosuppressed state <br> | ❑ [[Immunosuppression|Immunosuppressed state]] <br> | ||
❑ Acute trauma <br> | ❑ Acute [[trauma]] <br> | ||
❑ Relapsing pericarditis <br> | ❑ Relapsing pericarditis <br> | ||
</div>}} | </div>}} | ||
{{familytree | | | | | | |,|-|-|^|-|-|.| | | | | | | }} | {{familytree | | | | | | |,|-|-|^|-|-|-|-|.| | | | | }} | ||
{{familytree | | | | | | H01 | | | | | {{familytree | | | | | | H01 | | | | | | H02 | | | | H01=Yes| H02=No}} | ||
{{familytree | | | | |,|-|^|-|.| | | | | | | | | {{familytree | | | | | | |!| | | | | | | |!| | | | | H01=Yes| H02=No}} | ||
{{familytree | | | | J01 | | J02 | | | | | {{familytree | | | | | | H01 | | | | | | H02 | | | | H01=Inpatient treatment| H02=Outpatient treatment}} | ||
{{familytree | | | | |,|-|^|-|.| | | |,|-|^|-|.| | | | | }} | |||
{{familytree | | | | J01 | | J02 | | J03 | | J04 | | | | J01= Stable| J02= Unstable| J03= No pre-existing [[coronary artery disease]] | J04=Pre-existing [[coronary artery disease]]}} | |||
{{familytree | | | | |!| | | |!| | | | | | | |!| | | | |}} | {{familytree | | | | |!| | | |!| | | | | | | |!| | | | |}} | ||
{{familytree | | | | I02 | | I03 | | | {{familytree | | | | I02 | | I03 | | I04 | | I01 | | | | | I02=❑ [[NSAID's]] or [[aspirin]]<br> ❑ [[Colchicine]] may be used in recurrent or refractory disease<br> ❑[[Pericarditis 1 resident survival guide#Management#Etiology Specific Management|Clinical testing for underlying etiology]]| I03=<div style="float: left; text-align: left; padding:1em;">'''High risk features'''<br> | ||
❑ Immediately transfer the patient to ICU <BR> | ❑ Immediately transfer the patient to ICU <BR> | ||
❑ Telemetry monitoring and frequent vital checks <BR> | ❑ Telemetry monitoring and frequent vital checks <BR> | ||
❑ Call cardiology team immediately <br> | ❑ Call cardiology team immediately <br> | ||
❑ [[Cardiac tamponade resident survival guide| | ❑ [[Cardiac tamponade resident survival guide|Management of cardiac tamponade management]] <br> | ||
❑ Make sure patient is oxygenating well <BR> | ❑ Make sure patient is oxygenating well <BR> | ||
</div>| I01=<div style="float: left; text-align: left | ❑ [[Pericarditis 1 resident survival guide#Management#Etiology Specific Management|Clinical testing for underlying etiology]] <BR> | ||
❑ [[NSAID's]] or [[aspirin]]<br> ❑ [[Colchicine]]</div>| I01=<div style="float: left; text-align: left; padding:1em;">'''[[Aspirin]]'''<br> | |||
---- | ---- | ||
❑ [[aspirin|High-dose aspirin]]: <br> | ❑ [[aspirin|High-dose aspirin]]: <br> | ||
:❑ Orally 800 mg QID or TDS x 7-10 days <BR> | :❑ Orally 800 mg QID or TDS x 7-10 days <BR> | ||
:❑ Gradual tapering by 800 mg/week for 3 additional weeks <br> | :❑ Gradual tapering by 800 mg/week for 3 additional weeks <br> | ||
❑ Add gastroprotective agents <br> | |||
:❑ [[Misoprostol]] (600 to 800 mg/day)<BR> | |||
:❑ [[Omeprazole]] (20 mg/day) <br> | |||
❑ Stop anticoagulants if patient develops [[pericardial effusion]] <br> | |||
---- | |||
'''Steroids'''<br> | |||
---- | |||
❑ Avoid steroids to treat an initial episode of pericarditis <br> | |||
</div>| I04=<div style="float: left; text-align: left; padding:1em;">'''NSAID's'''<br> | |||
---- | |||
❑ [[Indomethacin]]: <br> | ❑ [[Indomethacin]]: <br> | ||
:❑ Orally 50 mg TDS x 1-2 weeks<br> | :❑ Orally 50 mg TDS x 1-2 weeks<br> | ||
:❑ Gradual tapering every 2-3 days for Rx period of 3-4 weeks<br> | :❑ Gradual tapering every 2-3 days for Rx period of 3-4 weeks<br> | ||
:❑ Avoid in [[coronary artery disease]] patients<br> | :❑ Avoid in [[coronary artery disease]] patients<br>Or<br> | ||
❑ [[Ibuprofen]]: <br> | ❑ [[Ibuprofen]]: <br> | ||
:❑ Orally 300-800 mg TDS or QID x 1-2 weeks<br> | :❑ Orally 300-800 mg TDS or QID x 1-2 weeks<br> | ||
Line 228: | Line 260: | ||
❑ Avoid steroids to treat an initial episode of pericarditis <br> | ❑ Avoid steroids to treat an initial episode of pericarditis <br> | ||
</div>}} | </div>}} | ||
{{familytree | | | | | | | | | | | | | | |,|-|^|-|.| | | }} | {{familytree | | | | | | | | | | | | |`|-|v|-|'| | | }} | ||
{{familytree | {{familytree | | | | | | | | | | | | | | J01 | | | J01=Response to Rx}} | ||
{{familytree | {{familytree | | | | | | | | | | | | |,|-|^|-|.| | | }} | ||
{{familytree | {{familytree | | | | | | | | | | | | J01 | | J02 | | J01= Yes | J02= No}} | ||
{{familytree | | | | | | | | | | | | |!| | | |!| | |}} | |||
{{familytree | | | | | | | | | | | | K01 | | K02 | | K01=<div style="float: left; text-align: left; padding:1em;">'''Follow up'''<br> | |||
❑ 7 to 10 days to assess response to treatment <br> | ❑ 7 to 10 days to assess response to treatment <br> | ||
❑ At 1 month check blood tests and CRP <BR> | ❑ At 1 month check blood tests and CRP <BR> | ||
❑ Thereafter only if symptoms recur <br> | ❑ Thereafter only if symptoms recur <br> | ||
</div>| K02= | </div>| K02= <div style="float: left; text-align: left; padding:1em;">'''Hospital admission'''<br> | ||
❑ Indication that the underlying cause may not be viral or idiopathic in nature. <br> | |||
❑ Inpatient therapy <BR> | |||
❑ [[Pericarditis 1 resident survival guide#Management#Etiology Specific Management|Etiology specific management]] <br> | |||
</div>}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Line 241: | Line 279: | ||
===Etiology Specific Management=== | ===Etiology Specific Management=== | ||
{|class="wikitable" | {|class="wikitable" | ||
! Clinical subgroups!! Specific investigations!! Treatment | ! Clinical subgroups!! Specific investigations!! Treatment | ||
|- | |- | ||
| Viral pericarditis|| | | Viral pericarditis|| ❑ Diagnostic [[pericardiocentesis]] <br> :❑ PCR or in-situ hybridisation || ❑ [[CMV]] pericarditis <br> :❑ Hyperimmunoglobulin OD 4 ml/kg on day 0, 4,and 8; 2 ml/kg on day 12 and 16.<br>❑ [[Coxsackie B]] pericarditis<br> :❑ Interferon alpha or beta 2,5 Mio. IU/m2 surface area s.c. 3 x per week<br> ❑ [[Adenovirus]] and [[parvovirus B19]] perimyocarditis <br> :❑ Immunoglobulin 10 g IV at day 1 and 3 for 6-8 hours | ||
|- | |||
| Bacterial pericarditis|| ❑ Diagnostic [[pericardiocentesis]]<br> :❑ [[Gram stain]], acid fast stain, fungal stain, and cultures of the pericardial fluid <br> :❑ Protein, glucose and cell count <br> ❑ Gram stain, acid fast stain, fungal stain, and cultures of other body fluids ||❑ Therapeutic [[pericardiocentesis]] or [[pericardial window]]<br> ❑ [[Pericardiectomy]] may be used in treatment of recurrent pericardial efussion and in patients with dense adhesions, loculated and thick purulent effusion<br> ❑ [[Pericarditis treatment#Management of Complicated Pericarditis|Antimicrobial therapy]] <br> :❑ Intiate antistaphylococcal antibiotic plus [[aminoglycoside]], followed by tailored antibiotic therapy according to pericardial fluid and blood cultures<br> :❑ Empiric regimen can be started for the following <br> ::❑ [[Immunosuppression]]<br> ::❑ Concurrent infection at another body site<br> ::❑ Presence of intravascular lines or prosthetic devices <br> ::❑ Recent antimicrobial therapy <br> ❑ [[Pericarditis treatment#Management of Complicated Pericarditis|Antifungal therapy]] | |||
|- | |||
| [[Tuberculous pericarditis]]||❑ [[CT scan]] and/or [[MRI]] of the chest <br> ❑ Culture of sputum, gastric aspirate, and/or urine <br> ❑ Diagnostic [[pericardiocentesis]] in all suspected tuberculous pericarditis patients <br> :❑ [[PCR]] of pericardial fluid<br>:❑ High [[adenosine deaminase]] activity and interferon gamma concentration in [[pericardial effusion]] <br> ❑ Pericardial biopsy (rapid diagnosis) <br> ❑ [[Tuberculin skin test]] (not helpful) <br> ❑ Enzyme-linked immunospot (ELISPOT)<br> ❑ Serum titres of antimyolemmal and antimyosin antibodies||❑[[Tuberculous pericarditis medical therapy|Anti-tuberculosis chemotherapy]]<br> :❑ Emperic therapy in TB endemic areas and in cases with high clinical suspicion<br> ❑ [[Pericardiectomy]] is warranted in the setting of persistent [[constrictive pericarditis]] or when no general improvement after 4-8 weeks following antituberculosis chemotherapy<br> ❑ [[Tuberculous pericarditis medical therapy#Role of Corticosteroids in Tuberculous pericarditis|Prednisone]] can be used. | |||
|- | |- | ||
| | | Neoplastic pericarditis ||❑ [[CT scan]] and/or [[MRI]] of the chest <br> ❑ Diagnostic [[pericardiocentesis]] <br> ❑ Pericardial biopsy || ❑ Systemic antineoplastic treatment <br> ❑ Assess the life expectancy of the patients before proceeding with the treatment<br> :❑ Better prognosis patients should be treated more aggressively <br> :❑ Advanced [[malignancy]] should be treated palliatively with [[pericardiocentesis]] <br> :❑ Recurrence of pericardial effusion is prevented using any of the following techniques <br> ::❑ Prolonged pericardiocentesis <br> ::❑ Pericardial sclerosis <br> ::❑ Pericardiotomy <br> ::❑ Intrapericardial chemotherapy | ||
|- | |- | ||
| | | Pericarditis in renal failure ||❑ Renal function test <br> ❑ Diagnostic [[pericardiocentesis]] <br> ❑ Pericardial biopsy || ❑ Uremic pericarditis <br> :❑ [[Hemodialysis]] or [[peritoneal dialysis]]<br> :❑ [[Heparin]]-free haemodialysis should be used <br> ❑ Dialysis-associated pericarditis <br> :❑ [[Pericardiocentesis]] for large effusion <br> :❑ Pericardiotomy in non resolving effusion<br> | ||
|- | |- | ||
|} | |} | ||
==Do's== | ==Do's== | ||
Line 267: | Line 308: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | |||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 21:26, 12 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]
Overview
Acute pericarditis refers to inflammation of the pericardial sac, which can be dry, fibrinous or effusive, independent from its aetiology. The term myopericarditis, or perimyocarditis, is used for cases of acute pericarditis that also demonstrate myocardial inflammation resulting in global or regional myocardial dysfunction, elevations of troponins, MB creatine-kinase, myoglobin and tumour necrosis factor.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Autoimmune: Rheumatoid arthritis, Sjögren’s syndrome, SLE, systemic sclerosis, systemic vasculitis
- Bacterial: Coxiella burnetii, pneumococcus, staphylococcus, streptococcus, tuberculosis
- Cardiovascular: Dressler's syndrome, post-myocardial infarction syndrome, postpericardiotomy syndrome, posttraumatic pericarditis
- Neoplastic: Breast cancer, leukemia, lung cancer, lymphoma
- Viral: Adeno virus, CMV, coxsackie, EBV, echovirus, HBV, HCV, HIV, HIV, human herpes virus 6, influenza, mumps, parvovirus B19, rubella, varicella
- Metabolic: Myxedema, uremia
Management
The following is an algorithm depicting the management of acute pericarditis in adults.[1][2][3]
Characterize the Clinical, EKG and imaging findings ❑ Characteristic chest pain
❑ Suggestive EKG changes
❑ Suggestive echocardiography changes
| |||||||||||||||||||||||||||||||||||||||||||||||||
Consider a possible diagnosis of acute pericarditis | |||||||||||||||||||||||||||||||||||||||||||||||||
Characterize the symptoms: Symptoms suggestive of pericarditis:
Symptoms associated with pericardial effusion:
❑ With a hemodynamically significant pericardial effusion
Other associated symptoms: Obtain a detailed history:
❑ Medications ❑ Systemic illness ❑ Others
| |||||||||||||||||||||||||||||||||||||||||||||||||
Examine the patient: ❑ Vitals
❑ Cardiovascular:
{{#ev:youtube|watch?v=EUCp_3_vwtw}}
❑ Respiratory system:
❑ Abdominal examination
| |||||||||||||||||||||||||||||||||||||||||||||||||
Order laboratory tests (urgent): ❑ CBC: Leucocytosis Order electrocardiogram (urgent): ❑ Typical findings in pericarditis
❑ Electrical alternans (in cardiac tamponade) Order imaging (urgent):
| |||||||||||||||||||||||||||||||||||||||||||||||||
Diagnosis of acute pericarditis: Atleast two of the following criteria: | |||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No or equivocal | ||||||||||||||||||||||||||||||||||||||||||||||||
❑ Acute pericarditis ❑ Myopericarditis * Elevated cardiac enzymes * Global or focal myocardial dysfunction on echo | Consider cardiac MRI (CMR) | Consider alternative diagnosis and treat accordingly | |||||||||||||||||||||||||||||||||||||||||||||||
Treat as acute pericarditis or myopericarditis if there is delayed enhancement on CMR | |||||||||||||||||||||||||||||||||||||||||||||||||
High risk features ❑ Fever >38°C | |||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||
Inpatient treatment | Outpatient treatment | ||||||||||||||||||||||||||||||||||||||||||||||||
Stable | Unstable | No pre-existing coronary artery disease | Pre-existing coronary artery disease | ||||||||||||||||||||||||||||||||||||||||||||||
❑ NSAID's or aspirin ❑ Colchicine may be used in recurrent or refractory disease ❑Clinical testing for underlying etiology | High risk features ❑ Immediately transfer the patient to ICU ❑ Colchicine | NSAID's ❑ Indomethacin:
❑ Ibuprofen:
❑ Add gastroprotective agents
Colchicine ❑ Alone or in combination with NSAIDs Steroids ❑ Avoid steroids to treat an initial episode of pericarditis | Aspirin
❑ Add gastroprotective agents
❑ Stop anticoagulants if patient develops pericardial effusion Steroids ❑ Avoid steroids to treat an initial episode of pericarditis | ||||||||||||||||||||||||||||||||||||||||||||||
Response to Rx | |||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||
Follow up ❑ 7 to 10 days to assess response to treatment | Hospital admission ❑ Indication that the underlying cause may not be viral or idiopathic in nature. | ||||||||||||||||||||||||||||||||||||||||||||||||
Etiology Specific Management
Clinical subgroups | Specific investigations | Treatment |
---|---|---|
Viral pericarditis | ❑ Diagnostic pericardiocentesis :❑ PCR or in-situ hybridisation |
❑ CMV pericarditis :❑ Hyperimmunoglobulin OD 4 ml/kg on day 0, 4,and 8; 2 ml/kg on day 12 and 16. ❑ Coxsackie B pericarditis :❑ Interferon alpha or beta 2,5 Mio. IU/m2 surface area s.c. 3 x per week ❑ Adenovirus and parvovirus B19 perimyocarditis :❑ Immunoglobulin 10 g IV at day 1 and 3 for 6-8 hours |
Bacterial pericarditis | ❑ Diagnostic pericardiocentesis :❑ Gram stain, acid fast stain, fungal stain, and cultures of the pericardial fluid :❑ Protein, glucose and cell count ❑ Gram stain, acid fast stain, fungal stain, and cultures of other body fluids |
❑ Therapeutic pericardiocentesis or pericardial window ❑ Pericardiectomy may be used in treatment of recurrent pericardial efussion and in patients with dense adhesions, loculated and thick purulent effusion ❑ Antimicrobial therapy :❑ Intiate antistaphylococcal antibiotic plus aminoglycoside, followed by tailored antibiotic therapy according to pericardial fluid and blood cultures :❑ Empiric regimen can be started for the following ::❑ Immunosuppression ::❑ Concurrent infection at another body site ::❑ Presence of intravascular lines or prosthetic devices ::❑ Recent antimicrobial therapy ❑ Antifungal therapy |
Tuberculous pericarditis | ❑ CT scan and/or MRI of the chest ❑ Culture of sputum, gastric aspirate, and/or urine ❑ Diagnostic pericardiocentesis in all suspected tuberculous pericarditis patients :❑ PCR of pericardial fluid :❑ High adenosine deaminase activity and interferon gamma concentration in pericardial effusion ❑ Pericardial biopsy (rapid diagnosis) ❑ Tuberculin skin test (not helpful) ❑ Enzyme-linked immunospot (ELISPOT) ❑ Serum titres of antimyolemmal and antimyosin antibodies |
❑Anti-tuberculosis chemotherapy :❑ Emperic therapy in TB endemic areas and in cases with high clinical suspicion ❑ Pericardiectomy is warranted in the setting of persistent constrictive pericarditis or when no general improvement after 4-8 weeks following antituberculosis chemotherapy ❑ Prednisone can be used. |
Neoplastic pericarditis | ❑ CT scan and/or MRI of the chest ❑ Diagnostic pericardiocentesis ❑ Pericardial biopsy |
❑ Systemic antineoplastic treatment ❑ Assess the life expectancy of the patients before proceeding with the treatment :❑ Better prognosis patients should be treated more aggressively :❑ Advanced malignancy should be treated palliatively with pericardiocentesis :❑ Recurrence of pericardial effusion is prevented using any of the following techniques ::❑ Prolonged pericardiocentesis ::❑ Pericardial sclerosis ::❑ Pericardiotomy ::❑ Intrapericardial chemotherapy |
Pericarditis in renal failure | ❑ Renal function test ❑ Diagnostic pericardiocentesis ❑ Pericardial biopsy |
❑ Uremic pericarditis :❑ Hemodialysis or peritoneal dialysis :❑ Heparin-free haemodialysis should be used ❑ Dialysis-associated pericarditis :❑ Pericardiocentesis for large effusion :❑ Pericardiotomy in non resolving effusion |
Do's
Dont's
References
- ↑ Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y; et al. (2004). "Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology". Eur Heart J. 25 (7): 587–610. doi:10.1016/j.ehj.2004.02.002. PMID 15120056.
- ↑ Klein AL, Abbara S, Agler DA, Appleton CP, Asher CR, Hoit B; et al. (2013). "American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography". J Am Soc Echocardiogr. 26 (9): 965–1012.e15. doi:10.1016/j.echo.2013.06.023. PMID 23998693.
- ↑ Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y (2010). "Controversial issues in the management of pericardial diseases". Circulation. 121 (7): 916–28. doi:10.1161/CIRCULATIONAHA.108.844753. PMID 20177006.